Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 367-377 |
Journal | Alzheimers & Dementia |
Volume | 6 |
Issue number | 5 |
DOIs | |
Publication status | Published - 2010 |
Requiring an amyloid-beta(1-42) biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials
L.S. Schneider, R.E. Kennedy, G.R. Cutter, N.C. Fox
Research output: Contribution to journal › Article › Academic › peer-review